Q3 2023 Holdings
Filed 2023-11-14 | 40 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $121.3M | 3,880,230 | 9.0% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $116.4M | 197,760 | 8.6% |
| Salesforce.com, Inc.(CRM) | COM | 79466L302 | $107.6M | 530,500 | 7.9% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $92.0M | 3,377,768 | 6.8% |
| Lanzatech Global Inc | COM | 51655R101 | $73.9M | 15,814,845 | 5.5% |
| Cable One Inc(CABO) | COM | 12685J105 | $72.9M | 118,403 | 5.4% |
| Taiwan Semiconductor MFG LTD(TSM) | SPONSORED ADS | 874039100 | $61.8M | 710,780 | 4.6% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $51.2M | 1,090,772 | 3.8% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $47.4M | 1,500,000 | 3.5% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $43.4M | 500,827 | 3.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $43.1M | 845,000 | 3.2% |
| Arcellx, Inc.(ACLX) | COMMON STOCK | 03940C100 | $38.6M | 1,075,000 | 2.9% |
| Apple Inc(AAPL) | COM | 037833100 | $37.9M | 221,460 | 2.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $35.4M | 400,000 | 2.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $34.8M | 6,071,703 | 2.6% |
| Seagen Inc.(SGENUSD) | COM | 81181C104 | $33.9M | 159,986 | 2.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $33.8M | 1,339,304 | 2.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $32.7M | 1,100,000 | 2.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $27.7M | 1,329,325 | 2.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.4M | 525,000 | 1.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $25.5M | 2,095,900 | 1.9% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $25.3M | 3,330,377 | 1.9% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $23.4M | 1,566,521 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $21.0M | 118,383 | 1.5% |
| Brookfield Asset Managmt LTD(BAM) | CL A LMT VTG SHS | 113004105 | $20.9M | 627,207 | 1.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $20.5M | 1,001,000 | 1.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $15.3M | 1,200,000 | 1.1% |
| Spruce Biosciences Inc | COM | 85209E109 | $15.2M | 6,722,336 | 1.1% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $11.9M | 60,000 | 0.9% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $8.1M | 5,747,067 | 0.6% |
| Rallybio Corp | COM | 75120L100 | $7.4M | 2,187,999 | 0.5% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $5.2M | 1,126,915 | 0.4% |
| Silk RD MED Inc | COM | 82710M100 | $5.0M | 333,884 | 0.4% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $4.7M | 360,000 | 0.3% |
| Lava Therapeutics NV | SHS | N51517105 | $3.5M | 2,400,000 | 0.3% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $2.6M | 441,558 | 0.2% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $1.9M | 676,379 | 0.1% |
| Galecto Inc(GLTOUSD) | COM | 36322Q107 | $1.8M | 2,497,791 | 0.1% |
| Kinnate Biopharma Inc | COM | 49705R105 | $1.1M | 815,707 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $567.4K | 468,902 | 0.0% |